Company intelligence / Profile preview

Elypta

Ownership: Private
Development stage: Commercial

Overview

Elypta has developed a novel, non-invasive liquid biopsy technology that measures glycosaminoglycan profiles ("GAGome") from blood or urine. This approach leverages machine learning to detect metabolic signatures of cancer. The company’s lead indication is early recurrence detection in renal cell carcinoma, with additional programs targeting multi-cancer early detection and hereditary cancer syndromes like Lynch Syndrome. Early results show high sensitivity and potential for broad application at low cost; large-scale European studies are ongoing.

Therapeutic areas: Oncology
Modalities: Device (liquid biopsy diagnostic platform)Non-pharmacological therapy (diagnostic test)Metabolomics-based assay
Industry: Metabolite Diagnostics

Drug pipeline

1 asset

MIRAM Kit

Commercial

Indications: Cancer detection, Cancer monitoring

Partnerships

European Commission Horizon Europe Mission on Cancer/PREDI-LYNCH consortium led by Oslo University Hospital

Beyond the preview

Go deeper on Elypta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elypta.

Explore the full profile